Background: The use of artificial intelligence in diabetic retinopathy has become a popular research focus in the past decade. However, no scientometric report has provided a systematic overview of this scientific area.
Aims: We utilized a bibliometric approach to identify and analyse the academic literature on artificial intelligence in diabetic retinopathy and explore emerging research trends, key authors, co-authorship networks, institutions, countries, and journals. We further captured the diabetic retinopathy conditions and technology commonly used within this area.
Methods: Web of Science was used to collect relevant articles on artificial intelligence use in diabetic retinopathy published between January 1, 2012, and December 31, 2022 . All the retrieved titles were screened for eligibility, with one criterion that they must be in English. All the bibliographic information was extracted and used to perform a descriptive analysis. Bibliometrix (R tool) and VOSviewer (Leiden University) were used to construct and visualize the annual numbers of publications, journals, authors, countries, institutions, collaboration networks, keywords, and references.
Results: In total, 931 articles that met the criteria were collected. The number of annual publications showed an increasing trend over the last ten years. Investigative Ophthalmology & Visual Science (58/931), IEEE Access (54/931), and Computers in Biology and Medicine (23/931) were the most journals with most publications. China (211/931), India (143/931, USA (133/931), and South Korea (44/931) were the most productive countries of origin. The National University of Singapore (40/931), Singapore Eye Research Institute (35/931), and Johns Hopkins University (34/931) were the most productive institutions. Ting D. (34/931), Wong T. (28/931), and Tan G. (17/931) were the most productive researchers.
Conclusion: This study summarizes the recent advances in artificial intelligence technology on diabetic retinopathy research and sheds light on the emerging trends, sources, leading institutions, and hot topics through bibliometric analysis and network visualization. Although this field has already shown great potential in health care, our findings will provide valuable clues relevant to future research directions and clinical practice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2023.107358 | DOI Listing |
Vestn Oftalmol
December 2024
Khabarovsk branch of S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery", Khabarovsk, Russia.
This article reviews the critical issue of diabetic retinopathy (DR) in pregnant women with diabetes mellitus (DM), and describes the current understanding of the features of DM progression during pregnancy, as well as its pathogenic mechanisms, risk factors, and preventive measures for manifestation and progression of DR during gestation.
View Article and Find Full Text PDFThe introduction of faricimab, a drug targeting both vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2, has enabled the implementation of the highly effective dual inhibition strategy in real clinical practice for patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), both previously treated with intravitreal injections and newly diagnosed. This article presents a series of 11 clinical cases involving patients with nAMD and DME who received loading doses of faricimab and continued ophthalmological observation. Among them, three patients with nAMD and two with DME were treatment-naïve, while the others were switched from alternative therapies to faricimab.
View Article and Find Full Text PDFUnlabelled: Diabetic macular edema (DME) is a leading cause of visual impairment and blindness among diabetic patients, its prevalence is continuing to increase worldwide. Faricimab, a bispecific antibody, represents a new generation of treatments for DME.
Purpose: This study presents an indirect comparison of the effectiveness and safety of faricimab versus other treatment options for DME.
BMC Ophthalmol
December 2024
Vitreoretina Department National Eye Center Cicendo Eye Hospital, Bandung, Indonesia.
Purpose: To evaluate early response of retinal sensitivity (RS) and retinal morphology in diabetic macular edema (DME) patients after intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment.
Methods: Sixteen eyes of 12 DME patients were included in this study conducted prospectively. All eyes underwent functional and morphologic examination of the macular area using microperimetry and optical coherence tomography (OCT) before and after intravitreal anti-VEGF injection.
Sci Rep
December 2024
Department of Endocrine and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
The correlation between thyroid hormone (TH) sensitivity and microvascular complications of type 2 diabetes mellitus (T2DM) remains uncertain. This study aimed to explore the association between TH sensitivity and the risk of diabetic kidney disease (DKD), diabetic retinopathy (DR), and diabetic neuropathy (DNP) in euthyroid T2DM patients. This study included a total of 946 hospitalized T2DM patients and calculated their sensitivity to the TH index, and each patient completed screenings for DKD, DR, and DNP.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!